Registry for people with depression or bipolar to receive psychiatry care
Treatments studied
Part of Mental health clinical trials.
This is a patient registry that enrolls people being evaluated for treatment options from an Interventional Psychiatry Service. It helps track patients with depression, bipolar disorder, or treatment-resistant OCD who are suitable for these psychiatry treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 99 years old
- You need to speak and understand enough English to consent and complete required study steps
- Your clinician must confirm you have a major depressive episode due to major depression, bipolar disorder, or treatment-resistant OCD
- You cannot have another main brain/mental diagnosis besides major depression or bipolar disorder
- You must not have serious, unstable medical problems that could affect safety (like uncontrolled organ disease or active cancer)
- If you might join any MRI part, you can’t have non-MRI-safe metal/implants, metal in your body, severe claustrophobia, or significant hearing loss
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an in-hospital brain stimulation treatment (TMS) for people with moderate to severe depression who did not improve after multiple antidepressant treatments. It may help your mood by targeting brain circuits involved in depression, and you would follow an intensive accelerated schedule.
This study uses a short questionnaire to figure out who is eligible to join future psychiatry research. It may help people get routed into studies that match their situation and safety needs.
This trial tests if deep brain stimulation (a device that sends tiny electrical pulses to mood-related brain areas) can help people with tough-to-treat depression. It uses brain-signal monitoring to see which patterns predict improvement.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This trial is for adults in Norway who are receiving specialized mental health care. It helps create a registry to improve understanding and treatment of mental health conditions.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.